Health Canada
- Status: approved
Glargine and regular insulin versus NPH and regular insulin (Glargine and regular insulin versus NPH and regular insulin) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
King Edward Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.